FDA Approval The latest news regarding FDA applications, processes, and approval. This section contains releases regarding the Food and Drug Administration’s consideration of new products, drugs, therapies and treatments. Find announcements covering every stage of the FDA application process, from filing to eventual approval, including appeals, resubmissions, and safety alerts.

Aug 15, 2014

14:30 ET

Aug 14, 2014

16:45 ET

Aug 14, 2014

16:35 ET

Aug 14, 2014

09:00 ET

Syneron Medical Ltd logo

Aug 13, 2014

13:08 ET

TMJ NextGeneration(TM) is a first-of-its-kind, FDA cleared medical device that is a safe and effective aid in reducing Temporomandibular Joint Disorder (TMJD) pain. The device consists of two custom-made, hollow ear canal inserts that allow full passage of sound and are practically invisible from the outside. (PRNewsFoto/TMJ Health, LLC)

Aug 13, 2014

10:07 ET

Aug 12, 2014

19:01 ET

FDA approves first noninvasive DNA screening test for colorectal cancer (PRNewsFoto/Exact Sciences Corp.)

Aug 12, 2014

09:00 ET

Aug 12, 2014

08:45 ET

OS2966 is an investigational therapy developed by W. Shawn Carbonell, MD, PhD, Founder and CEO of OncoSynergy (pictured), for the potential treatment of aggressive solid cancers including glioblastoma. (Photo credit: Jackson Solway) (PRNewsFoto/OncoSynergy, Inc.)

Aug 11, 2014

18:18 ET

Aug 11, 2014

10:50 ET

Aug 11, 2014

08:00 ET

Aug 11, 2014

07:00 ET

Aug 11, 2014

07:00 ET

Aug 08, 2014

19:15 ET

http://www.multivu.com/players/English/7288451-janssen-pharmaceuticals-fda-approved-invokamet-type-2-diabetes/gallery/image/2245cacc-b245-46fe-b426-f788a88626a7.HR.jpg

Aug 07, 2014

17:48 ET

Aug 07, 2014

16:45 ET

BDSI Logo.  (PRNewsFoto/BioDelivery Sciences International, Inc.)

Aug 07, 2014

14:54 ET

At NextSource Biotechnology, Our mission is to become the leading biotechnology innovator with a niche business model that utilizes the most in-demand "Mature Drugs" in the market today to establish a unified Private Label Portfolio of enhanced medications with newly approved FDA indications to support todays more affordable alternative medical treatments. Additionally, our goal is to provide a secure and consistent supply of all products enabling us to maintain the highest level of availability at all times.  (PRNewsFoto/NextSource BioTechnology, LLC)

Aug 06, 2014

08:00 ET

Aug 05, 2014

14:49 ET

Jump to news releases